Evaluation of an Experimental Web-based Educational Module on Opioid-related Occupational Safety Among Police Officers: Protocol for a Randomized Pragmatic Trial to Minimize Barriers to Overdose Response.
Evaluation of an Experimental Web-based Educational Module on Opioid-related Occupational Safety Among Police Officers: Protocol for a Randomized Pragmatic Trial to Minimize Barriers to Overdose Response.
复制标题
DOI：
10.2196/33451
复制
发表时间：
2022-02-25
影响因子：
1.7
通讯作者：
Dastparvardeh N
中科院分区：
文献类型：
--
作者：
Simmons J;Elliott L;Bennett AS;Beletsky L;Rajan S;Anders B;Dastparvardeh N
随着与毒品有关的发病率和死亡率继续激增，警察处于北美过量（OD）危机的第一线。禁毒执法塑造了吸毒者（PWUD）的健康风险，同时也影响了官员的职业健康和健康。对使执法做法与公共卫生和职业安全目标相一致的有效干预措施的研究仍然不足。阿片类药物和警察安全研究旨在改变警察在PWUD方面的做法。它适应和评估课程的相对有效性，该课程将公共卫生促进内容与职业风险降低（ORR）捆绑在一起，以补充基于网络的OD响应和纳洛酮培训平台（GetNaloxoneNow.org或GNN）。这种新方法有可能改善公共卫生和职业安全实践，包括使用纳洛酮逆转ODs，将PWUD转介给治疗和其他支持服务，并避免没收注射器。本纵向研究采用随机实用试验设计。来自宾夕法尼亚州、佛蒙特州和新罕布什尔州OD致死率较高的选定县的300名现役警察样本将随机（各n=150）分配至实验组（GNN + OPS）或对照组（GNN + COVID-19 ORR）。将对所有300名警官进行培训前和培训后调查，然后对他们进行为期12个月的季度调查。还将同时采用嵌入式混合方法，对一个次级抽样的警官进行质量跟踪。从纽约大学机构审查委员会获得研究伦理批准。结果将提供一个了解的经验，知识和执法人员的这一样本的看法。将使用广义线性模型分析2个研究组中每个研究组的受试者之间以及多个时间点的关键行为结局差异（预期检测的最小效应量，d=0.50）。研究结果将广泛传播，一旦研究完成，培训产品将在全国提供。OPS是第一项纵向评估基于网络的阿片类药物相关ORR干预对美国执法的影响的研究。我们的随机实用临床试验旨在消除警察与PWUD/注射毒品者进行救生接触的障碍，方法是关注执法的安全性以及与阿片类药物OD风险人群合作的循证和最佳实践。我们同时嵌入的混合方法的方法将提供实证评估的执法之间的纳洛酮为基础的反应的扩散。ClinicalTrail.gov NCT 05008523; https://clinicaltrials.gov/show/NCT05008523 DERR 1 -10.2196/33451
As drug-related morbidity and mortality continue to surge, police officers are on the front lines of the North American overdose (OD) crisis. Drug law enforcement shapes health risks among people who use drugs (PWUD), while also impacting the occupational health and wellness of officers. Effective interventions to align law enforcement practices with public health and occupational safety goals remain underresearched. The Opioids and Police Safety Study (OPS) aims to shift police practices relating to PWUD. It adapts and evaluates the relative effectiveness of a curriculum that bundles content on public health promotion with occupational risk reduction (ORR) to supplement a web-based OD response and naloxone training platform (GetNaloxoneNow.org, or GNN). This novel approach has the potential to improve public health and occupational safety practices, including using naloxone to reverse ODs, referring PWUD to treatment and other supportive services, and avoiding syringe confiscation. This longitudinal study uses a randomized pragmatic trial design. A sample of 300 active-duty police officers from select counties in Pennsylvania, Vermont, and New Hampshire with high OD fatality rates will be randomized (n=150 each) to either the experimental arm (GNN + OPS) or the control arm (GNN + COVID-19 ORR). A pre- and posttraining survey will be administered to all 300 officers, after which they will be administered quarterly surveys for 12 months. A subsample of police officers will also be qualitatively followed in a simultaneous embedded mixed-methods approach. Research ethics approval was obtained from the New York University Institutional Review Board. Results will provide an understanding of the experiences, knowledge, and perceptions of this sample of law enforcement personnel. Generalized linear models will be used to analyze differences in key behavioral outcomes between the participants in each of the 2 study arms and across multiple time points (anticipated minimum effect size to be detected, d=0.50). Findings will be disseminated widely, and the training products will be available nationally once the study is completed. The OPS is the first study to longitudinally assess the impact of a web-based opioid-related ORR intervention for law enforcement in the U.S. Our randomized pragmatic clinical trial aims to remove barriers to life-saving police engagement with PWUD/people who inject drugs by focusing both on the safety of law enforcement and evidence-based and best practices for working with persons at risk of an opioid OD. Our simultaneous embedded mixed-methods approach will provide empirical evaluation of the diffusion of the naloxone-based response among law enforcement. ClinicalTrail.gov NCT05008523; https://clinicaltrials.gov/show/NCT05008523 DERR1-10.2196/33451